Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Trend Edge Setup Score
Trend Edge rates DNTH Bullish with a Setup Score of 0, net conviction 43, actionability 0. How the Setup Score works →
Total Setup Score
0
Directional Bias
Bullish
Net Conviction
43
Actionability
0 (in range)
Key signals behind this score
40wk Uptrend — rising+above (sma 61.82 vs px 97.48)
80wk Uptrend — rising+above (sma 41.94 vs px 97.48)
200wk Uptrend — rising+above (sma 27.81 vs px 97.48)
Funds Accumulating — momZ +4.56 · 1.88→2.68
Short Squeeze Setup — velZ +0.83 · age 47w×0.78 · 12.25%
About Dianthus Therapeutics Inc.
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: September 12, 2023
Headquarters: 7 Times Square, New York, NY, United States, 10036
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$87.77
Near-term / short-term trend
Weekly
40-Week SMA
$61.82
Medium-term trend
Weekly
80-Week SMA
$41.94
Cyclical trend (business cycle)
Weekly
200-Week SMA
$27.81
Secular trend (multi-year)
Monthly
10-Month SMA
$63.03
Near-term monthly trend
Monthly
20-Month SMA
$42.01
Medium-term monthly trend
Monthly
40-Month SMA
$30.41
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Dianthus Therapeutics Inc.
(DNTH) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.